Defense Secretary Pete Hegseth's new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement therapy and hormone treatment for transgender men in the military.
U.S. District Judge Ana Reyes in Washington raised the question Wednesday in an ongoing lawsuit against President Donald Trump's ban on transgender troops. Reyes noted that Trump's ban says “the Armed Forces must adhere to high mental and physical health standards ... without the benefit of routine medical treatment or special provisions.”
